Facebook, Google and Amazon join fight against cancer

 Date: 11:00AM GMT 01 Mar 2013Source: The Telegraph   Facebook, Google and Amazon have teamed up with Cancer Research UK to design a mobile game that will allow members of the public to help the search for new cancer drugs.   Researchers are working hard to identify the genetic faults that drive cancer  Photo: ANDREW SHAW The project will allow smartphone users to play to investigate vital scientific data at the same time as playing a mobile game. The first step is for 40 computer programmers, gamers, graphic designers and other specialists to take part in a weekend "GameJam" to turn the charity's raw genetic data into a game format for future so-called "citizen scientists". "We're making great progress in understanding the genetic reasons cancer develops. But the clues to why some drugs will work and some won't are held in data which need to be analysed by the human eye - and this could take years," said Carlos Caldas at Cancer Research UK's Cambridge Institute. "By harnessing the collective power of citizen scientists we'll accelerate the discovery of new ways to diagnose and treat cancer much more precisely." After the GameJam, which runs in London from March 1-3, an agency will build the game concept into reality and the team plans to launch it in mid 2013.  CRUK's scientists are working hard to identify the genetic faults that drive cancer to try to find new ways of diagnosing and treating patients in a more targeted way based on their genetic profile [...]

2013-03-01T14:22:23-07:00March, 2013|Oral Cancer News|

Cancer medicine is stuck in the past

Source: www.technologyreview.com Author: Susan Young Pathologists and doctors are using a 19th century definition of cancer to diagnose the disease, which leads to unnecessary treatment in some cases, according to Otis Brawley, Chief Medical Officer of the American Cancer Society. Speaking on Thursday at the 2012 TEDMED conference, Brawley called for a 21st century approach to cancer diagnosis; and a modern, genomics-based appreciation of cancer so that patients don't undergo surgeries and chemotherapy for tumors that pose little threat. Pathologists still use drawings made in 1840 to determine whether the cells in a biopsy are cancerous or not, said Brawley. When a lump is deemed to be cancerous, surgery often follows. But as many as 25% of breast cancers and, by some estimates, 60% of prostate cancers could be left untreated and merely monitored, he said. Brawley said the medical community needs to use genomic sequencing to identify the genetic signals of those cancers that doctors need to watch and those that need to be treated. This could be achieved by sequencing tumors from different cancer patients and looking for a genetic "profile" that is associated with dangerous, stable, or benign cancers.

Go to Top